Physician profile
John Kelley
NPI 1063414555
$1,147.31
in general payments reported to CMS, 2019-2025
19 companies · $124 in 2025
The $124 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $148 · 2020: $54.47 · 2021: $89.03 · 2022: $361 · 2023: $203 · 2024: $167 · 2025: $124.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $419 · Education: $74.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $419.41 |
| Education | $74.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $403.68 | 2019-2023 | |
| Pfizer INC. | $139.57 | 2019-2025 | |
| Astellas Pharma US INC | $136.24 | 2023-2025 | Veozah |
| Hologic Sales and Service, LLC | $65.48 | 2023-2024 | Thinprep 2000 Processor, Aptima |
| Daiichi Sankyo INC. | $61.64 | 2022 | |
| Scynexis, INC. | $42.74 | 2022 | |
| Momentis Surgical INC. | $40.00 | 2022 | |
| Exact Sciences Corporation | $37.50 | 2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $34.87 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $30.20 | 2025 | Myfembree |
| Mayne Pharma Commercial LLC | $24.87 | 2023 | |
| Aspira Women'S Health INC | $22.32 | 2024 | Ova1 |
| Evofem Biosciences, INC. | $22.20 | 2022 | |
| Medtronic, INC. | $16.62 | 2022 | |
| Therapeuticsmd, INC. | $16.20 | 2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mckesson Medical-Surgical, INC. | $15.95 | 2025 | |
| Agile Therapeutics, INC. | $13.96 | 2022 | |
| Minerva Surgical, INC | $11.78 | 2019 | |
| Covidien LP | $11.49 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Kelley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.